Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Carcinoma, Non-Small-Cell Lung × Etoposide × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 3 Leukemia, Myeloid, Acute 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Leukemia 1 Congenital Abnormalities 1 Burkitt Lymphoma 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Pemetrexed 15 Carboplatin 14 Cisplatin 12 Paclitaxel 9 pembrolizumab 6 Gemcitabine 5 Crizotinib 5 osimertinib 4 Nivolumab 4 amivantamab 3 Ipilimumab 3 Docetaxel 3 Afatinib 3 trastuzumab deruxtecan 2 selpercatinib 2 lorlatinib 2 lazertinib 2 durvalumab 2 cemiplimab 2 Gefitinib 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 zenocutuzumab 1 trametinib 1 tepotinib 1 telisotuzumab vedotin 1 taletrectinib 1 sacituzumab govitecan 1 repotrectinib 1 pralsetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡